N/A
N=550
Translating Research Into Practice: Patient Navigation for Breast Cancer
Cancer, Breast
Bottom Line
View on ClinicalTrials.gov: NCT03514433 ↗Enrolled (actual)
550
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Time-to-treatment Post-diagnosis — 44.78; 45.40 days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- TRIP Patient Navigation Intervention (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Boston Medical Center
- Primary completion
- Sep 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time-to-treatment Post-diagnosis |
44.78; 45.40 | — |
Summary
The TRIP Project aims to overcome barriers to widespread implementation and dissemination of evidence-based practices that will improve the delivery of guideline-concordant care to vulnerable women with breast cancer. To accomplish this goal the study team will create (a) regional patient registries; (b) systematic screening for social barriers to care with a personalized referral plan; and (c) patient navigation services that integrate into one model of care to improve the quality and effectiveness of care delivery, for minority and/or low-income women with breast cancer in Boston.
Eligibility Criteria
Inclusion Criteria
- are an adult female 18 years of age or older;
- reside within 25 miles of the City of Boston;
- have any of the following risk factors for delays in care: are Black and/or Hispanic ethnicity, do not speak English as their primary language, and/or have only public insurance or are uninsured at the time of diagnosis.
Exclusion Criteria
- cancer diagnosis made > 60 days prior to enrollment, such that the ability of the intervention to effect the outcome is limited;
- presence of a cognitive impairment such as dementia or delirium from any cause (e.g. metabolic, medication or drug induced), given the unique challenges to their treatment decision making/ adherence and the fact that the intervention would not include the patient directly, but rather the family;
- home residence is outside of the city of Boston, Massachusetts.
Data sourced from ClinicalTrials.gov (NCT03514433). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.